Principal Financial Group’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-9,094
| Closed | -$290K | – | 2174 |
|
2024
Q4 | $290K | Buy |
9,094
+86
| +1% | +$2.74K | ﹤0.01% | 2041 |
|
2024
Q3 | $260K | Sell |
9,008
-3,877
| -30% | -$112K | ﹤0.01% | 2056 |
|
2024
Q2 | $494K | Sell |
12,885
-71,719
| -85% | -$2.75M | ﹤0.01% | 1962 |
|
2024
Q1 | $4.97M | Buy |
84,604
+60,741
| +255% | +$3.57M | ﹤0.01% | 1568 |
|
2023
Q4 | $1.43M | Sell |
23,863
-3,120
| -12% | -$187K | ﹤0.01% | 1799 |
|
2023
Q3 | $1.03M | Sell |
26,983
-23,973
| -47% | -$912K | ﹤0.01% | 1836 |
|
2023
Q2 | $4.64M | Buy |
50,956
+25,416
| +100% | +$2.32M | ﹤0.01% | 1550 |
|
2023
Q1 | $1.68M | Sell |
25,540
-47,442
| -65% | -$3.13M | ﹤0.01% | 1790 |
|
2022
Q4 | $3.77M | Buy |
72,982
+47,936
| +191% | +$2.48M | ﹤0.01% | 1618 |
|
2022
Q3 | $1.71M | Sell |
25,046
-204
| -0.8% | -$13.9K | ﹤0.01% | 1747 |
|
2022
Q2 | $1.14M | Buy |
25,250
+946
| +4% | +$42.8K | ﹤0.01% | 1895 |
|
2022
Q1 | $1.24M | Buy |
24,304
+1,696
| +8% | +$86.2K | ﹤0.01% | 1938 |
|
2021
Q4 | $1.07M | Sell |
22,608
-7,301
| -24% | -$345K | ﹤0.01% | 1970 |
|
2021
Q3 | $986K | Buy |
29,909
+972
| +3% | +$32K | ﹤0.01% | 2005 |
|
2021
Q2 | $1.83M | Sell |
28,937
-672
| -2% | -$42.5K | ﹤0.01% | 1934 |
|
2021
Q1 | $1.27M | Sell |
29,609
-1,215
| -4% | -$52.2K | ﹤0.01% | 1943 |
|
2020
Q4 | $1.76M | Buy |
30,824
+5,832
| +23% | +$334K | ﹤0.01% | 1821 |
|
2020
Q3 | $754K | Sell |
24,992
-1,152
| -4% | -$34.8K | ﹤0.01% | 1924 |
|
2020
Q2 | $854K | Buy |
26,144
+16,528
| +172% | +$540K | ﹤0.01% | 1858 |
|
2020
Q1 | $258K | Buy |
9,616
+318
| +3% | +$8.53K | ﹤0.01% | 2003 |
|
2019
Q4 | $285K | Buy |
9,298
+531
| +6% | +$16.3K | ﹤0.01% | 2062 |
|
2019
Q3 | $211K | Buy |
8,767
+120
| +1% | +$2.89K | ﹤0.01% | 2134 |
|
2019
Q2 | $219K | Buy |
+8,647
| New | +$219K | ﹤0.01% | 2129 |
|